CRP and depressive disorder: Using a similar paradigm, another study is assessing the impact of carbidopa/levodopa, the anti-Parkinsonian dopamine pro-drug, on resting state functional connectivity in classic reward circuitry and anhedonic depression using a CRP cut-off to enrich the patient cohort.